Angelo De Marzo

Professor

Johns Hopkins University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Angelo De Marzo is a Professor at the Johns Hopkins School of Medicine in the United States. His research primarily focuses on prostate cancer, specifically exploring the roles of fibroblast activation, immune responses to androgen deprivation therapy, and the challenges of defining precancer. His recent publications highlight significant findings related to the prognosis and therapeutic potential of stromal components in prostate cancer, as well as utilizing artificial intelligence to predict disease recurrence.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Yasutomo Nakai

Osaka International Cancer Institute

JAPAN

View details

Otis Brawley

Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

W. Nathaniel Brennen

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Masashi Nakayama

Osaka International Cancer Institute

JAPAN

View details

Levent Trabzonlu

Loyola University Medical Center

UNITED STATES

View details

Jonathan Melamed

New York University

UNITED STATES

View details

Christopher Heaphy

Assistant Professor

Boston University School of Medicine

UNITED STATES

View details

Sarah R. Amend

Assistant Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Angelo De Marzo

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Overexpression of fibroblast activation protein (FAP) in the stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate

Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer

Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer

FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer

Defining precancer: a grand challenge for the cancer community

Presence of cells in the polyaneuploid cancer cell (PACC) state predicts the risk of recurrence in prostate cancer

Progressive Spreading of DNA Methylation in the GSTP1 Promoter CpG Island across Transitions from Precursors to Invasive Prostate Cancer

Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities

Predicting biochemical recurrence of prostate cancer with artificial intelligence

Health inequity drives disease biology to create disparities in prostate cancer outcomes

Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer

Genomic and Clinicopathologic Characterization of ATM-deficient Prostate Cancer

High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes

Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes

Collaborators (8)

Yasutomo Nakai

Otis Brawley

W. Nathaniel Brennen

Masashi Nakayama

Levent Trabzonlu

Jonathan Melamed

Christopher Heaphy

Sarah R. Amend

Make your next move.